COP11 to Convene in Geneva in November; South Korea May Leverage Global Consensus to Advance Tobacco-Control Reforms

Sep.05.2025
COP11 to Convene in Geneva in November; South Korea May Leverage Global Consensus to Advance Tobacco-Control Reforms
The 11th Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) will be held in Geneva, Switzerland, from November 7 to 22, 2025. The meeting is expected to focus on the disclosure of tobacco constituents, environmental impacts, and industry responsibility. South Korea plans to implement the Tobacco Harmfulness Management Act in November and is preparing to send a delegation to COP11 to help align domestic regulations with international standards.

Key Points

 

  • Dates and role: COP11 will take place Nov. 7–22, 2025, in Geneva. The FCTC COP is the authoritative forum where more than 180 Parties to the WHO Framework Convention on Tobacco Control discuss global tobacco-control rules.
  • Focus topics: Regulation of testing and disclosure of tobacco constituents (Articles 9 and 10), environment (Article 18), and industry liability (Article 19).
  • Domestic progress: South Korea’s Tobacco Harmfulness Management Act will take effect on Nov. 1, with scientific assessments planned for all tobacco product categories.
  • Historical milestone: COP5 was held in Seoul in 2012, where the Protocol to Eliminate Illicit Trade in Tobacco Products was adopted by consensus.
  • Recent outcomes: At COP10 in 2024, the Korean delegation reported that the adult smoking rate fell to 17.7% in 2022.
  • What’s next: Amendments to the Tobacco Business Act—including whether to regulate synthetic nicotine as “tobacco”—have stalled. Consensus reached at COP11 is seen as a potential external driver for domestic policy and tax adjustments.

 


 

2Firsts, September 5, 2025 — According to news.nate, the 11th Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) will be held in Geneva, Switzerland, from Nov. 7 to 22, 2025. As the mechanism through which more than 180 FCTC Parties negotiate global tobacco-control policies and international standards, the FCTC COP is regarded as a key decision-making platform in tobacco policy.

 

The conference is expected to prioritize regulation of testing and public disclosure of tobacco constituents (Articles 9 and 10 of the Convention), environmental issues linked to tobacco (Article 18), and industry liability (Article 19). Government delegations will report on implementation of the Convention and discuss concrete policy directions such as new regulatory measures, tax frameworks, and environmental responses.

 

In South Korea, the Tobacco Harmfulness Management Act will formally take effect on Nov. 1, with scientific assessments to be conducted across all tobacco product categories. Aligning domestic systems with international standards has been identified as a near-term implementation priority. Korea has long participated in the FCTC process: COP5 was held in Seoul in 2012—the first in East Asia—where the Protocol to Eliminate Illicit Trade in Tobacco Products was adopted unanimously. At COP10 in Panama in 2024, the Korean delegation reported that, through legislation and sustained anti-smoking campaigns, the adult smoking rate fell to a record low of 17.7% in 2022.

 

Against the backdrop of slow-moving National Assembly deliberations on amendments to the Tobacco Business Act—such as whether to classify synthetic nicotine under tobacco regulation—experts expect that any international consensus emerging from COP11 could provide a basis for domestic adjustments to taxation and regulation, thereby directly shaping Korea’s tobacco-control framework. The government is currently forming its delegation to COP11.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Vape Manufacturer Ispire Expands Malaysia Operations, Negotiates Southeast Asia OEM Deal as Nicotine Pouch and US Age-Gating Businesses Develop
Vape Manufacturer Ispire Expands Malaysia Operations, Negotiates Southeast Asia OEM Deal as Nicotine Pouch and US Age-Gating Businesses Develop
US-listed vaping technology and manufacturing company Ispire Technology reported fiscal first-quarter 2027 revenue of $27.5 million on November 9, 2026, down 9.3% year over year but up 3.2% sequentially. Gross margin recovered to 16.2%, while its net loss widened to $6.4 million from $3.3 million a year earlier. Management attributed the sales decline primarily to tighter European vaping regulation and reduced distributor orders. Ispire is expanding manufacturing in Malaysia and negotiating an OEM/ODM agreement with a Southeast Asian vaping brand, with an announcement anticipated in January 2027. The company estimates that Malaysian manufacturing offers an approximately 25% US tariff advantage over China-based production. However, it continues to purchase products from Shenzhen Yi Jia Technology Co., Ltd., a manufacturer controlled by its chairman, and reported $52 million in non-current related-party payables at September 30.
company
Nov.11 by 2Firsts Perspectives
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania's Act 57 vape directory regime will reach the end of its 120-day inventory transition period on Oct. 19. Nicotine-containing e-cigarettes intended for retail sale in the state that are not listed on the Attorney General's ENDS directory will then be barred from retail sale and treated as contraband subject to seizure, forfeiture and destruction. Manufacturers face annual product certification, brand- and style-based fees and a minimum $50,000 surety bond, while retailers and wholesalers must source through licensed channels and monitor the directory.
Regulations
Oct.08
Beyond IQOS ILUMA, PMI Expands Lower-Priced BONDS Heated Tobacco Platform: Seven Markets Added in Q3, With Rollouts in Japan, Europe and North Africa
Beyond IQOS ILUMA, PMI Expands Lower-Priced BONDS Heated Tobacco Platform: Seven Markets Added in Q3, With Rollouts in Japan, Europe and North Africa
Philip Morris International (PMI) is expanding the international footprint of BONDS by IQOS, its lower-priced heated tobacco platform. The company's third-quarter 2026 SEC filing shows that BONDS devices and BLENDS tobacco sticks were available in 15 markets at the end of September, up from eight at the end of June. In November, PMI announced plans to extend sales from three to 17 Japanese prefectures and introduced BONDS in Spain and Morocco. The platform uses ROUNDHEAT external heating technology and proprietary tobacco sticks, separate from the IQOS ILUMA system. In Japan, BONDS retails for ¥2,980, approximately 25% below ILUMA i ONE, while BLENDS costs ¥570 per pack. PMI management says BONDS targets cigarette smokers who have not adopted heated tobacco. Separate sales and revenue figures remain undisclosed.
company
Nov.06
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Four CrossBar 20K disposable e-cigarettes appeared on Pennsylvania's 163-entry ENDS directory ahead of enforcement beginning October 19, 2026. The devices feature 13mL e-liquid reservoirs, 50mg/mL nicotine, 2,000mAh batteries and 0.9Ω mesh coils, with advertised puff counts of up to 20,000. CrossBar was the only modern high-puff disposable series among the directory's 15 disposable entries. Its packaging emphasizes New York design and Japanese-origin flavoring, while historical CrossBar records identify a registered U.S. tobacco manufacturing-related establishment. The link between the newer 13mL devices and earlier 1.3mL PMTA filings remains unconfirmed.
product
Oct.26